Skip to content

The effect of laughter therapy in patients with gastrointestinal cancers

The effect of laughter therapy on anxiety in patients with gastrointestinal cancers undergoing chemotherapy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200819048458N1
Enrollment
60
Registered
2020-10-07
Start date
2019-08-23
Completion date
Unknown
Last updated
2020-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant neoplasms of digestive organs. Malignant neoplasms of digestive organs

Interventions

Intervention 1: Intervention group: In the intervention group, laughter therapy performed with comedy videos and humorous clips for 30 minutes once a day for 3 consecutive days. Intervention 2: Contro

Sponsors

Ardabil University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Willingness to participate in the study Having a gastrointestinal cancers Existence of anxiety based on visual analog scale Do not have audible and visual problems Do not use radiotherapy along with chemotherapy

Exclusion criteria

Exclusion criteria: Discharge from the hospital Death of the patient Absence of the patient in laughter therapy sessions even once increase or decrease the dose of anxiety medication during the intervention

Design outcomes

Primary

MeasureTime frame
Anxiety in patients undergoing chemotherapy. Timepoint: 30 min before and 30 min after laughter therapy in both groups and daily for three days. Method of measurement: spilberger anxiety questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehdi Ajri-khameslou

Ardabil University of Medical Sciences

ajri.mehdi@gmail.com+98 45 3372 6085

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026